Molecular switch controlling immune suppression may help turn up immunotherapies

A strategy to maximize the effectiveness of anti-cancer immune therapy has been developed by a group of researchers who have identified a molecular switch that controls immune suppression. This discovery opens the possibility to further improving and refining emerging immunotherapies that boost the body’s own abilities to fight diseases ranging from cancer to Alzheimer’s and Crohn’s disease.